The TULIP system was the first apparatus designed specifically for las
er ablation of the prostate. Laser energy is delivered under ultrasoun
d guidance with the probe moved distally from the bladder neck at the
rate of 0.5 to 1 mm/sec. The aim is to produce a deep level of coagula
tion necrosis, Postoperatively, patients have a suprapubic catheter un
til they can void comfortably. As of 1994, 2-year results showed a 69%
reduction in the mean Boyarsky symptom score (N = 57) v 63% at 6 mont
hs (N = 212) and a mean increase in the peak urine flow rate of 68% (N
= 46) v 59% at 6 months (N = 195). At present, it is not clear whethe
r TULIP will become commercially available in the United States.